Your browser doesn't support javascript.
loading
Sex-specific impact of patterns of imageable tumor growth on survival of primary glioblastoma patients.
Whitmire, Paula; Rickertsen, Cassandra R; Hawkins-Daarud, Andrea; Carrasco, Eduardo; Lorence, Julia; De Leon, Gustavo; Curtin, Lee; Bayless, Spencer; Clark-Swanson, Kamala; Peeri, Noah C; Corpuz, Christina; Lewis-de Los Angeles, Christine Paula; Bendok, Bernard R; Gonzalez-Cuyar, Luis; Vora, Sujay; Mrugala, Maciej M; Hu, Leland S; Wang, Lei; Porter, Alyx; Kumthekar, Priya; Johnston, Sandra K; Egan, Kathleen M; Gatenby, Robert; Canoll, Peter; Rubin, Joshua B; Swanson, Kristin R.
Afiliação
  • Whitmire P; Precision Neurotherapeutics Innovation Program, Mayo Clinic, 5777 East Mayo Blvd , SSB 02-700, Phoenix, AZ, 85054, USA. paula.whitmire@gmail.com.
  • Rickertsen CR; Precision Neurotherapeutics Innovation Program, Mayo Clinic, 5777 East Mayo Blvd , SSB 02-700, Phoenix, AZ, 85054, USA.
  • Hawkins-Daarud A; Precision Neurotherapeutics Innovation Program, Mayo Clinic, 5777 East Mayo Blvd , SSB 02-700, Phoenix, AZ, 85054, USA.
  • Carrasco E; Precision Neurotherapeutics Innovation Program, Mayo Clinic, 5777 East Mayo Blvd , SSB 02-700, Phoenix, AZ, 85054, USA.
  • Lorence J; Precision Neurotherapeutics Innovation Program, Mayo Clinic, 5777 East Mayo Blvd , SSB 02-700, Phoenix, AZ, 85054, USA.
  • De Leon G; School of Life Sciences, Arizona State University, Tempe, AZ, USA.
  • Curtin L; Precision Neurotherapeutics Innovation Program, Mayo Clinic, 5777 East Mayo Blvd , SSB 02-700, Phoenix, AZ, 85054, USA.
  • Bayless S; Precision Neurotherapeutics Innovation Program, Mayo Clinic, 5777 East Mayo Blvd , SSB 02-700, Phoenix, AZ, 85054, USA.
  • Clark-Swanson K; Centre for Mathematical Medicine and Biology, University of Nottingham, Nottingham, UK.
  • Peeri NC; Precision Neurotherapeutics Innovation Program, Mayo Clinic, 5777 East Mayo Blvd , SSB 02-700, Phoenix, AZ, 85054, USA.
  • Corpuz C; Precision Neurotherapeutics Innovation Program, Mayo Clinic, 5777 East Mayo Blvd , SSB 02-700, Phoenix, AZ, 85054, USA.
  • Lewis-de Los Angeles CP; Cancer Epidemiology Program, Moffitt Cancer Center, Tampa, FL, USA.
  • Bendok BR; Department of Neurology, Columbia University Medical Center, New York, NY, USA.
  • Gonzalez-Cuyar L; Northwestern University Interdepartmental Neuroscience Program, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Vora S; Precision Neurotherapeutics Innovation Program, Mayo Clinic, 5777 East Mayo Blvd , SSB 02-700, Phoenix, AZ, 85054, USA.
  • Mrugala MM; Department of Neurologic Surgery, Mayo Clinic, Phoenix, AZ, USA.
  • Hu LS; Department of Pathology, Division of Neuropathology, University of Washington, Seattle, WA, USA.
  • Wang L; Department of Radiation Oncology, Mayo Clinic, Phoenix, AZ, USA.
  • Porter A; Department of Neurology, Mayo Clinic, Phoenix, AZ, USA.
  • Kumthekar P; Department of Radiology, Mayo Clinic, Phoenix, AZ, USA.
  • Johnston SK; Department of Radiology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
  • Egan KM; Department of Neurology, Mayo Clinic, Phoenix, AZ, USA.
  • Gatenby R; Department of Neurology, Robert H Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Canoll P; Precision Neurotherapeutics Innovation Program, Mayo Clinic, 5777 East Mayo Blvd , SSB 02-700, Phoenix, AZ, 85054, USA.
  • Rubin JB; Department of Radiology, University of Washington, Seattle, WA, USA.
  • Swanson KR; Cancer Epidemiology Program, Moffitt Cancer Center, Tampa, FL, USA.
BMC Cancer ; 20(1): 447, 2020 May 19.
Article em En | MEDLINE | ID: mdl-32429869
BACKGROUND: Sex is recognized as a significant determinant of outcome among glioblastoma patients, but the relative prognostic importance of glioblastoma features has not been thoroughly explored for sex differences. METHODS: Combining multi-modal MR images, biomathematical models, and patient clinical information, this investigation assesses which pretreatment variables have a sex-specific impact on the survival of glioblastoma patients (299 males and 195 females). RESULTS: Among males, tumor (T1Gd) radius was a predictor of overall survival (HR = 1.027, p = 0.044). Among females, higher tumor cell net invasion rate was a significant detriment to overall survival (HR = 1.011, p < 0.001). Female extreme survivors had significantly smaller tumors (T1Gd) (p = 0.010 t-test), but tumor size was not correlated with female overall survival (p = 0.955 CPH). Both male and female extreme survivors had significantly lower tumor cell net proliferation rates than other patients (M p = 0.004, F p = 0.001, t-test). CONCLUSION: Despite similar distributions of the MR imaging parameters between males and females, there was a sex-specific difference in how these parameters related to outcomes.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Imageamento por Ressonância Magnética / Glioblastoma Limite: Adolescent / Adult / Aged / Aged80 / Child / Female / Humans / Male / Middle aged Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Imageamento por Ressonância Magnética / Glioblastoma Limite: Adolescent / Adult / Aged / Aged80 / Child / Female / Humans / Male / Middle aged Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos